Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coagulation Disorder Neonatal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00364182
What this trial is testing

Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia B

Who this might be right for
Hemophilia B
Pfizer 50
Large-scale testing (Phase 3)Study completedNCT01775618
What this trial is testing

Safety and Efficacy of BAY94-9027 in Previously Treated Male Children With Haemophilia A

Who this might be right for
Hemophilia A
Bayer 73
Large-scale testing (Phase 3)Study completedNCT03020160
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Emicizumab Given Every 4 Weeks in Participants With Hemophilia A

Who this might be right for
Hemophilia A
Hoffmann-La Roche 48
Not applicableStudy completedNCT07101224
What this trial is testing

Data Registry in Chinese Hemophilia A and B Patients

Who this might be right for
Hemophilia AHemophilia B
Institute of Hematology & Blood Diseases Hospital, China 200
Not applicableStudy completedNCT02199717
What this trial is testing

An Institutional Pilot Study to Investigate Physical Activity Patterns in Boys With Hemophilia

Who this might be right for
Hemophilia AHemophilia BFactor VIII Deficiency+1 more
The Hospital for Sick Children 66
Not applicableStudy completedNCT01220141
What this trial is testing

Observational Study on Safety of Room Temperature Stable NovoSeven® in Patients With Haemophilia A or B

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 51
Not applicableLooking for participantsNCT05630651
What this trial is testing

The Efficacy and Safety of ZS801 in Chinese Hemophilia B Patients.

Who this might be right for
Hemophilia B
Institute of Hematology & Blood Diseases Hospital, China 6
Not applicableUnknownNCT02622646
What this trial is testing

Personalized Prophylactic Treatment With Advate® in Severe or Moderate Haemophilia A Patients

Who this might be right for
Hemophilia AFactor VIII
Hospital Universitario La Fe 25
Testing effectiveness (Phase 2)Study completedNCT02554773
What this trial is testing

An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 34
Not applicableStudy completedNCT00167973
What this trial is testing

Prospective Registry of European Hemophilia B Patients Receiving BeneFIX® for Usual Use

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 218
Not applicableStudy completedNCT02581969
What this trial is testing

Extension at 10 Years of the: "Observational Study Evaluating Efficacy and Costs of Secondary Prophylaxis vs On-demand Therapy With Kogenate Bayer in Patients With Severe Haemophilia A."

Who this might be right for
Hemophilia A
Bayer 43
Not applicableUnknownNCT00006319
What this trial is testing

Molecular and Clinical Studies of Primary Immunodeficiency Diseases

Who this might be right for
Wiskott- Aldrich SyndromeADA Deficient SCID
National Human Genome Research Institute (NHGRI) 266
Not applicableStudy completedNCT02546622
What this trial is testing

ATHN 2: Factor Switching Study

Who this might be right for
Hemophilia
American Thrombosis and Hemostasis Network 310
Not applicableLooking for participantsNCT07414511
What this trial is testing

Hemophilia A Research Program

Who this might be right for
Hemophilia AHemophilia A, SevereFactor VIII (FVIII)+10 more
University of Washington 500
Large-scale testing (Phase 3)Study completedNCT03549871
What this trial is testing

Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis

Who this might be right for
Hemophilia
Genzyme, a Sanofi Company 80
Early research (Phase 1)Study completedNCT04072237
What this trial is testing

Study of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia

Who this might be right for
Hemophilia AHemophilia BHemophilia A With Inhibitor+3 more
Catalyst Biosciences 11
Not applicableStudy completedNCT02796222
What this trial is testing

Factor Product Utilization and Health Outcomes in Patients With Hemophilia

Who this might be right for
Hemophilia A, CongenitalHemophilia B, Congenital
University of British Columbia 61
Post-approval studies (Phase 4)Study completedNCT00586521
What this trial is testing

BAY14-2222 Prophylaxis and Joint Function Improvement (Adults)

Who this might be right for
Hematologic DiseaseHemophilia A
Bayer 20
Early research (Phase 1)Study completedNCT00922792
What this trial is testing

Safety and Mode of Action of a Single Dose and Multiple Doses of Long Acting Activated Recombinant Human Factor VII in Patients With Haemophilia A and B

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 8
Testing effectiveness (Phase 2)Ended earlyNCT05164471
What this trial is testing

Phase 1/2 Dose Confirmation Study of FLT180a in Hemophilia B

Who this might be right for
Hemophilia B
Spur Therapeutics 6
Next Page